The Endocrine Club

22/03/2026

Induced Hyperglycemia
Glucose lowering therapy should be initiated when preprandial glucose repeatedly exceed 7.8 (140 mg/dL) or
post-prandial glucose 11.1 mmol/L (200 mg/dL),
J. Clin. Med. 2021, 10, 2154

Send a message to learn more

21/03/2026

For women with gestational diabetes who have a fasting plasma glucose level below 7 mmol/litre at diagnosis, offer a trial of diet and exercise changes.

NICE 2020

21/03/2026

Advise pregnant women with diabetes who are taking insulin to maintain their capillary plasma glucose level above 4 mmol/litre (72 )

NICE 2020

21/03/2026

For women with gestational diabetes who have a fasting plasma glucose level of 7.0 mmol/litre or above at diagnosis, offer: immediate treatment with insulin, with or without metformin

NICE 2020

21/03/2026

Continue ACEi or ARB therapy unless
s.creatinine rises by more than 30% within 4 weeks
following initiation of treatment or an increase in dose

KDIGO2022

21/03/2026

Aspirin and preeclampsia

The effect of aspirin on the risk of preeclampsia based on the Fetal Medicine Foundation first-trimester risk https://ow.ly/H9u650Yw6ze

20/03/2026

For patients with diabetes, albuminuria, and normal blood pressure, treatment with an ACEi or ARB ( MAY )be considered.
small percentage of patients in RENAAL IRMA IDENT were normotensive
KDIGO2022

20/03/2026

In comparison to metformin , SGLT2i have weaker effects on HbA1c, particularly with an
eGFR

20/03/2026

For women with gestational diabetes who have a fasting plasma glucose level of between 6.0 and 6.9 mmol/litre and complications such as macrosomia or hydramnios, consider immediate treatment with insulin, with or without metformin

NICE 2020

20/03/2026

For women who have had gestational diabetes in a previous pregnancy, offer:
-early self‑monitoring of blood glucose or
- 75-g 2‑hour OGTT as soon as possible after booking (whether in the first or second trimester), and a further 75-g 2‑hour OGTT at 24 to 28 weeks if the results of the first OGTT are normal
NICE 2015

19/03/2026

Nocturnal hypertension was associated with an increased risk of composite cardiovascular outcomes

Hypertension22 January 2026

19/03/2026

Glucose monitoring in those who receive >20 mg prednisolone or equivalent particularly in high risk to develop Sterooid Induced Hyperglycemia SIHG (e.g., advanced age, higher BMI, prediabetes or family history of diabetes).

J. Clin. Med. 2021, 10, 2154